In June 2022, we learnt that MESOX was shortlisted as a Finalist at the RSC’s Emerging Technologies Competition under its Health Category. This is the 10th year for this competition and we are delighted to receive the news at this important time in our journey!

The news serves as further validation of MESOX’s technology for overcoming the delivery challenges of therapeutic molecules helping to unlock their potential in the fight against diseases and delivering value to our partner’s programmes.